covid
Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo Efetividade e segurança de vildagliptina comparativamente com outros antidiabé...
Journal Information

Statistics

Follow this link to access the full text of the article

Artigo original
Efetividade e segurança de vildagliptina comparativamente com outros antidiabéticos orais em doentes com diabetes tipo 2: estudo EDGE em Portugal
Effectiveness and safety of vildagliptin compared to other oral antidiabetic drugs in patients with type 2 diabetes: EDGE study in Portugal
João Jácome de Castroa, Mafalda Marcelinoa, João Miguel Fernandesb,
Corresponding author
joao.fernandes@novartis.com

Autor para correspondência.
, Chantal Mathieuc, Giovanni Baderd, em nome dos Investigadores do estudo EDGE em Portugal
a Serviço de Endocrinologia, Diabetes e Metabolismo, Hospital das Forças Armadas, Lisboa, Portugal
b Novartis Farma SA, Porto Salvo, Portugal
c Experimental Medicine and Endocrinology Section, Catholic University of Leuven, Leuven, Belgium
d Novartis Pharma AG, Basel, Switzerland
Read
10722
Times
was read the article
1994
Total PDF
8728
Total HTML
Share statistics
Article information
ISSN: 16463439
Original language: Portuguese
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 30 2 32
2025 11 108 36 144
2025 10 95 47 142
2025 9 81 32 113
2025 8 104 22 126
2025 7 96 16 112
2025 6 91 10 101
2025 5 99 17 116
2025 4 111 19 130
2025 3 87 8 95
2025 2 82 15 97
2025 1 129 4 133
2024 12 63 11 74
2024 11 90 5 95
2024 10 72 16 88
2024 9 86 19 105
2024 8 95 16 111
2024 7 79 3 82
2024 6 67 7 74
2024 5 68 8 76
2024 4 87 7 94
2024 3 128 7 135
2024 2 152 7 159
2024 1 156 10 166
2023 12 151 11 162
2023 11 164 5 169
2023 10 156 17 173
2023 9 103 13 116
2023 8 96 14 110
2023 7 108 5 113
2023 6 86 7 93
2023 5 242 6 248
2023 4 224 9 233
2023 3 240 2 242
2023 2 149 6 155
2023 1 114 5 119
2022 12 52 5 57
2022 11 84 10 94
2022 10 82 12 94
2022 9 54 26 80
2022 8 46 16 62
2022 7 47 10 57
2022 6 53 19 72
2022 5 80 9 89
2022 4 65 9 74
2022 3 59 14 73
2022 2 53 5 58
2022 1 90 13 103
2021 12 62 11 73
2021 11 66 7 73
2021 10 56 12 68
2021 9 60 12 72
2021 8 47 12 59
2021 7 42 10 52
2021 6 56 20 76
2021 5 63 7 70
2021 4 271 28 299
2021 3 108 52 160
2021 2 62 12 74
2021 1 73 17 90
2020 12 70 18 88
2020 11 48 7 55
2020 10 43 6 49
2020 9 74 15 89
2020 8 70 10 80
2020 7 66 2 68
2020 6 47 12 59
2020 5 68 17 85
2020 4 66 13 79
2020 3 52 7 59
2020 2 65 8 73
2020 1 46 5 51
2019 12 56 14 70
2019 11 48 5 53
2019 10 41 8 49
2019 9 50 11 61
2019 8 41 6 47
2019 7 43 17 60
2019 6 96 32 128
2019 5 143 62 205
2019 4 73 44 117
2019 3 72 5 77
2019 2 51 13 64
2019 1 80 9 89
2018 12 71 7 78
2018 11 50 8 58
2018 10 36 16 52
2018 9 34 5 39
2018 8 20 22 42
2018 7 32 35 67
2018 6 37 50 87
2018 5 28 22 50
2018 4 59 27 86
2018 3 80 43 123
2018 2 29 42 71
2018 1 16 32 48
2017 12 43 36 79
2017 11 37 45 82
2017 10 41 40 81
2017 9 37 36 73
2017 8 32 12 44
2017 7 32 17 49
2017 6 40 28 68
2017 5 30 23 53
2017 4 29 15 44
2017 3 29 21 50
2017 2 25 15 40
2017 1 24 7 31
2016 12 39 19 58
2016 11 41 24 65
2016 10 58 23 81
2016 9 22 14 36
2016 8 30 14 44
2016 7 28 24 52
2016 6 2 0 2
2016 5 1 0 1
2016 4 48 14 62
2016 3 71 42 113
2016 2 79 39 118
2016 1 79 32 111
2015 12 10 7 17
Show all

Follow this link to access the full text of the article